A Randomized Two-Period Crossover, Clinical Bioequivalence Study Comparing the Pharmacokinetics of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) Formulation Versus Taxol in Patients With Advanced Cancer.
Phase of Trial: Phase I
Latest Information Update: 27 Nov 2013
At a glance
- Drugs Paclitaxel (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors INSYS Therapeutics, Inc; NeoPharm Inc
- 30 Jun 2011 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 25 Jul 2006 Status change
- 18 Aug 2005 New trial record.